Zika Virus Vaccines by Company Profile, Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development
Report Summary :
It is predicted that Zika virus vaccines shot will available to the public by 2018.
Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar epidemiology, clinical presentation and transmission cycle in urban environments as chikungunya and dengue, although it generally causes milder illness.
The report concludes with the profiles of major players in the Zika virus vaccines development such as Sanofi Pasteur, ImmunoVaccines Inc, Inovio Pharmaceuticals, Inc, Valneva, Bharat Biotech International Pvt. Ltd., NewLink Genetics. The major players are evaluated on various parameters such as company overview, product outlook and Zika virus vaccines latest development and trends.
Table of Contents
For More Details VISIT @ https://www.grandresearchstore.com/pharmaceuticals/zika-virus-vaccines-by-company-profile-deals-type-funding-clinical-trials-insight-regulatory-landscape-%26-recent-development
It is predicted that Zika virus vaccines shot will available to the public by 2018.
Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar epidemiology, clinical presentation and transmission cycle in urban environments as chikungunya and dengue, although it generally causes milder illness.
The report concludes with the profiles of major players in the Zika virus vaccines development such as Sanofi Pasteur, ImmunoVaccines Inc, Inovio Pharmaceuticals, Inc, Valneva, Bharat Biotech International Pvt. Ltd., NewLink Genetics. The major players are evaluated on various parameters such as company overview, product outlook and Zika virus vaccines latest development and trends.
Table of Contents
1. Executive Summary
2. Zika Virus – Introduction, Signs and Symptoms,
Transmission, Diagnosis, Treatment & Prevention
3. Current Situation & Areas with Zika Virus
4. Competitive Landscape of the Zika Virus Vaccines
Companies
5. Funding in Zika Virus Vaccines Research
6. Zika Virus Vaccines – Clinical Trials Insight by Phase
& Trial Status
7. Zika Virus Vaccines – Regulatory Landscape
8. Key Companies Analysis For More Details VISIT @ https://www.grandresearchstore.com/pharmaceuticals/zika-virus-vaccines-by-company-profile-deals-type-funding-clinical-trials-insight-regulatory-landscape-%26-recent-development
Comments
Post a Comment